Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
9.28
0.27 (3.05%)
At close: Aug 20, 2025, 3:59 PM
9.38
1.08%
After-hours: Aug 20, 2025, 07:54 PM EDT
Zevra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 62.02M | 40.59M | 23.61M | 24.79M | 23.99M | 28.01M | 27.46M | 16.56M | 16.54M | 9.37M | 10.46M | 10.72M | 9.81M | 20.5M | 28.65M | 28.43M | 28.39M | 23.32M |
Cost of Revenue | 17.39M | 8.59M | 10.51M | 11.93M | 9.77M | 6.87M | 3.73M | 1.09M | 1.09M | 460K | 343K | 259K | 118K | 1.07M | 2.06M | 2M | 2M | 1.64M |
Gross Profit | 44.63M | 32M | 13.11M | 12.86M | 14.22M | 21.14M | 23.73M | 15.47M | 15.46M | 8.91M | 10.12M | 10.46M | 9.69M | 19.43M | 26.59M | 26.43M | 26.39M | 21.67M |
Operating Income | -119.12M | -71.88M | -87M | -86.26M | -74.32M | -57.17M | -49.6M | -25.76M | -17.02M | -17.48M | -6.42M | -18.43M | -14.03M | -1.09M | 7.73M | 7.36M | 8.37M | 5.13M |
Interest Income | 976K | 1.25M | 2.17M | 2.46M | 3.15M | 4.43M | 4.54M | 4.92M | 3.4M | 2.22M | 1.28M | 803K | 722K | 356K | 257K | 234K | 145K | 185K |
Pretax Income | 21.4M | -75.36M | -90.14M | -84.92M | -61.89M | -47.19M | -42.37M | -36.27M | -32.73M | -52.33M | -42.33M | -35.94M | -31.05M | -93K | -8.52M | -10.71M | -11.99M | -17.34M |
Net Income | 2.64M | -91.99M | -105.51M | -84.92M | -62.07M | -47.23M | -42.37M | -36.24M | -32.49M | -51.45M | -41.54M | -35.23M | -30.37M | -123K | -8.55M | -10.71M | -11.96M | -17.33M |
Selling & General & Admin | 72.66M | 64.48M | 54.87M | 53.4M | 43.01M | 37.41M | 34.31M | 24.73M | 22.89M | 19.44M | 15.34M | 12.82M | 10.8M | 9.54M | 8.7M | 8.67M | 8.15M | 7.57M |
Research & Development | 27.55M | 34.64M | 42.09M | 42.63M | 43.98M | 40.89M | 39.02M | 17.26M | 10.35M | 7.71M | 1.95M | 16.07M | 12.93M | 10.98M | 10.16M | 10.41M | 9.88M | 8.98M |
Other Expenses | 3.21M | 4.76M | 3.15M | 3.09M | 1.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 103.42M | 103.88M | 100.11M | 99.12M | 88.53M | 78.3M | 73.33M | 42M | 33.24M | 27.16M | 17.29M | 28.89M | 23.72M | 20.52M | 18.86M | 19.08M | 18.03M | 16.55M |
Interest Expense | 3.5M | 3.6M | 6.3M | 4.86M | 3.97M | 2.05M | 1.5M | 763K | 521K | 360K | 183K | 170K | 52K | 41K | 385K | 1.99M | 3.73M | 5.47M |
Selling & Marketing Expenses | 14.52M | 25.52M | 25.52M | 11M | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 122.43M | 112.47M | 110.61M | 111.04M | 98.3M | 85.17M | 77.06M | 43.09M | 34.33M | 27.62M | 17.64M | 29.15M | 23.84M | 21.59M | 20.92M | 21.08M | 20.03M | 18.19M |
Income Tax Expense | 16.39M | 14.26M | 15.37M | n/a | 177K | 33K | n/a | -34K | -244K | -885K | -786K | -718K | -679K | -3K | 1K | -33K | -73K | 1.74M |
Shares Outstanding (Basic) | 54.78M | 54.1M | 53.67M | 47.81M | 41.9M | 41.78M | 37.9M | 34.72M | 33.9M | 34.47M | 34.51M | 34.49M | 34.45M | 34.51M | 35.35M | 35.22M | 29.17M | 19.15M |
Shares Outstanding (Diluted) | 56.32M | 54.1M | 53.67M | 47.81M | 41.9M | 41.78M | 37.9M | 34.72M | 33.9M | 34.47M | 34.51M | 34.49M | 34.45M | 34.51M | 35.35M | 35.22M | 29.17M | 19.15M |
EPS (Basic) | -0.06 | -1.9 | -2.24 | -1.97 | -1.58 | -1.25 | -1.19 | -1.05 | -0.94 | -1.49 | -1.2 | -1.02 | -0.88 | 0.03 | -0.46 | -1.45 | -2.08 | -2.08 |
EPS (Diluted) | -0.21 | -1.9 | -2.24 | -1.97 | -1.58 | -1.25 | -1.19 | -1.05 | -0.94 | -1.49 | -1.2 | -1.02 | -0.88 | 0.03 | -0.46 | -1.45 | -2.08 | -2.08 |
EBITDA | -115.16M | -60.3M | -76.4M | -73.76M | -57.9M | -46.6M | -44.96M | -39.81M | -32.5M | -52.16M | -41.2M | -35.06M | -30.63M | -189K | -8.27M | -8.82M | -8.37M | -11.61M |
EBIT | 29.88M | -66.78M | -82.79M | -79.29M | -61.88M | -49.09M | -46.27M | -40.64M | -33.66M | -53.42M | -42.15M | -35.77M | -31M | -52K | -8.14M | -8.72M | -8.27M | -11.9M |
Depreciation & Amortization | 6.57M | 6.48M | 6.39M | 5.53M | 3.97M | 2.49M | 1.01M | 519K | 855K | 958K | 944K | 708K | 375K | 258K | 257K | 259K | 261K | 265K |